Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy

Haematologica

Volumn 90, Issue 5, 2005, Pages 698-700

  Molica, Stefano ^a,c   Vacca, Angelo ^b   Tucci, Luigi ^b   Ribatti, Domenico ^a  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c Medical Oncology Unit   (Italy)

Author keywords

Angiogenesis; CLL; Fludarabine

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; CHLORAMBUCIL; FLUDARABINE;

ADULT; AGED; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; BONE MARROW; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW; CHLORAMBUCIL; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM, RESIDUAL; NEOVASCULARIZATION, PATHOLOGIC; VIDARABINE;

EID: 20344374175     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994;87:503-8.
2. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, et al. Angiogenesis in acute and chronic leukaemia and myelodysplastic syndromes. Blood 2000;96:2240-5.
3. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukaemia. Blood 2000;95:309-13.
4. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997;150:815-21.
5. Molica S, Vacca A, Ribatti D, Cuneo A, Cavazzini F, Levato D, et al. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood 2002; 100:3344-51.
6. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, et al. National Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-7.
7. Kumar S, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, et al. Bone marrow angiogenesis in multiple myeloma: effect of therapy. Br J Haematol 2002;119:665-71.
8. Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma. Leukemia 1999;13:468-72.
9. Kumar S, Witzig TE, Dispenzieri A, Lacy MQ, Wellik LE, Fonseca R, et al. Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma. Leukemia 2004;18: 624-7.
10. Kvasnicka HM, Thiele J, Staib P, Schmitt-Graeff A, Griesshammer M, Klose J, et al. Reversal of bone marrow angiogenesis in chronic myeloid leukemia following imatinib mesylate (STI571) therapy. Blood 2004;103:3549-51.